Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
Incyte Corporation
M.D. Anderson Cancer Center
University of California, Irvine
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
Incyte Corporation
University of Southern California
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
University Hospital, Angers
Thomas Jefferson University
Constellation Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Ohio State University Comprehensive Cancer Center
Hangzhou GluBio Pharmaceutical Co., Ltd.
PharmaEssentia
PharmaEssentia
PharmaEssentia
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
RWTH Aachen University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Italfarmaco
Icahn School of Medicine at Mount Sinai
AbbVie
University Hospital, Angers
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Fox Chase Cancer Center
University of Utah
University of Nebraska
University Health Network, Toronto
Herlev Hospital
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Northwestern University
Roswell Park Cancer Institute
Novartis
Fred Hutchinson Cancer Center
CTI BioPharma
M.D. Anderson Cancer Center
Hamad Medical Corporation
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center